Food/Recall·openFDA/food

LEASA Industries Co., Inc. — Class I: LEASA Alfalfa Sprouts; packaged in plastic clamshell containers; KEEP REFRIGERATED; NET WT

HighPublished Oct 14, 2026· AI-analyzed Oct 20, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

LEASA Industries Co., Inc. has initiated a Class I recall of 6 oz. plastic clamshell containers of Alfalfa Sprouts due to potential E. coli contamination in the seeds used for production. The recall is currently classified as ongoing.

Who it affects

This affects LEASA Industries Co., Inc., raw seed suppliers, and QA/Supply Chain teams involved in the distribution and monitoring of fresh alfalfa sprouts in the United States.

Why it matters

A Class I classification signifies a situation where there is a reasonable probability that exposure to the product will cause serious adverse health consequences or death. The focus on contaminated seeds suggests a potential vulnerability in the upstream supply chain or raw material testing protocols, requiring heighted vigilance in vendor oversight for produce manufacturers.

Practical takeaway

Conduct immediate inventory reconciliations for the specified UPC. Review supplier qualification protocols for raw seed inputs, ensuring testing for Shiga toxin-producing E. coli is robust. Document all disposal or return activities in alignment with the ongoing Class I recall status.

FDA source material

Class I. Reason: Seeds may have been contaminated with E.coli. Product: LEASA Alfalfa Sprouts; packaged in plastic clamshell containers; KEEP REFRIGERATED; NET WT. 6 OZ. (170g); Grown & Packaged by: LEASA Industries Co., Inc., Mami FL 33147; Product of USA; UPC: 0 75465 11111 0. Firm: LEASA Industries Co., Inc. (Miami FL United States). Status: Ongoing.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.